Post-Operative Alertness and Recovery. Sugammadex Versus Neostigmine/Glycopyrrolate and Placebo

Trial Profile

Post-Operative Alertness and Recovery. Sugammadex Versus Neostigmine/Glycopyrrolate and Placebo

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Oct 2013

At a glance

  • Drugs Sugammadex (Primary) ; Glycopyrrolate; Neostigmine
  • Indications Neuromuscular blockade
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Oct 2013 New trial record
    • 16 Oct 2013 Results presented at the 2013 Annual Meeting of the American Society of Anesthesiologists.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top